$0.6303
At close: Jan 23, 7:30 PM EDT
$0.6499
0.023.11%
After Hours: 7:30 PM EDT
Comments
Loading...
bioAffinity Technologies (BIAF) Forecast
NewsEarningsbioAffinity Technologies (BIAF) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestbioAffinity Technologies (NASDAQ:BIAF) Stock Quotes, Forecast and News Summary
bioAffinity Technologies Stock (NASDAQ: BIAF) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy bioAffinity Technologies (BIAF) stock?
You can purchase shares of bioAffinity Technologies (NASDAQ:BIAF) through any online brokerage.
Who are bioAffinity Technologies (BIAF) competitors?
Other companies in bioAffinity Technologies’s space includes: Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Cellectar Biosciences (NASDAQ:CLRB) and Can Fite Biofarma (AMEX:CANF).
What is the forecast, or price target, for bioAffinity Technologies (BIAF) stock?
bioAffinity Technologies has a consensus price target of $6.00.
What is the current price for bioAffinity Technologies (BIAF)?
The stock price for bioAffinity Technologies (NASDAQ: BIAF) is $0.6499 last updated January 23, 2025 at 7:30 PM EST.
Does bioAffinity Technologies (BIAF) pay a dividend?
There are no upcoming dividends for bioAffinity Technologies.
When is bioAffinity Technologies (NASDAQ:BIAF) reporting earnings?
bioAffinity Technologies’s Q4 earnings are confirmed for Monday, March 31, 2025.
Is bioAffinity Technologies (BIAF) going to split?
There is no upcoming split for bioAffinity Technologies.
What sector and industry does bioAffinity Technologies (BIAF) operate in?
bioAffinity Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.